Nano-X Imaging Ltd. header image

Nano-X Imaging Ltd.

NNOX

Equity

ISIN IL0011681371 / Valor 56410599

NASDAQ (2026-03-27)
USD 2.21-2.64%

Nano-X Imaging Ltd.
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Nano-X Imaging Ltd. is a NASDAQ-listed medical imaging company dedicated to making advanced diagnostic technologies more affordable and accessible, thereby promoting preventive healthcare. The company leverages its proprietary digital X-ray source and artificial intelligence to offer a comprehensive ecosystem that includes the Nanox.ARC Digital Tomosynthesis system, which provides cost-effective and user-friendly imaging, and Nanox.AI, which enhances CT scans by identifying early signs of chronic diseases. Additionally, Nano-X provides Nanox.CLOUD, a cloud-based platform for managing and analyzing imaging data, and Nanox.MARKETPLACE, a decentralized service that connects users with radiology and cardiology experts through teleradiology services. By integrating these technologies, Nano-X aims to streamline the imaging process from scan to diagnosis, improve early detection and treatment, and ultimately enhance health outcomes on a global scale.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-59.5%1Y
-62.9%3Y
-94.4%5Y

Performance

66.6%1Y
88.3%3Y
85.0%5Y

Volatility

Market cap

144 M

Market cap (USD)

Daily traded volume (Shares)

966,144

Daily traded volume (Shares)

1 day high/low

7.605 / 7

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Intra-Cellular Therapies Inc
Intra-Cellular Therapies Inc Intra-Cellular Therapies Inc Valor: 23194616
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 131.87
Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-7.98%USD 18.16
GE Healthcare Technologies Inc
GE Healthcare Technologies Inc GE Healthcare Technologies Inc Valor: 123735674
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.23%USD 69.23
Option Care Health Inc
Option Care Health Inc Option Care Health Inc Valor: 52359365
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.73%USD 27.27
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.56%EUR 26.00
Laboratorios Farmaceuticos Rovi, SA
Laboratorios Farmaceuticos Rovi, SA Laboratorios Farmaceuticos Rovi, SA Valor: 3591807
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.57%EUR 78.90
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.10%CHF 312.50
Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc Madrigal Pharmaceuticals Inc Valor: 33395434
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.56%USD 510.68
Evotec SE
Evotec SE Evotec SE Valor: 505433
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.60%EUR 4.30
Limes Schlosskliniken AG
Limes Schlosskliniken AG Limes Schlosskliniken AG Valor: 38625581
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.83%EUR 476.00